Aclaris Therapeutics, Inc.ACRSNASDAQ

Revenue (LTM)

$8M

-58.2% YoY

Net Income (LTM)

$-65M

+50.8% YoY

Free Cash Flow

$-47M

Revenue CAGR (5Y)

+3.8%

Marginsimproving

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	7	30↑340.1%	31↑5.0%	19↓40.1%	8↓58.2%
Gross Profit	2	18↑768.8%	13↓26.0%	16↑21.0%	6↓64.0%
Operating Income	-90	-90↓0.1%	-97↓8.4%	-142↓45.8%	-76↑46.2%
Net Income	-91	-87↑4.4%	-88↓1.8%	-132↓49.3%	-65↑50.8%
EBITDA	-64	-84↓30.9%	-115↓36.9%	-52↑55.2%	-64↓24.7%
EPS Diluted	-1.60	-1.33↑16.9%	-1.27↑4.5%	-1.71↓34.6%	-0.53↑69.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	27	45↑65.6%	40↓11.9%	25↓38.4%	20↓18.8%
Total Current Assets	205	232↑12.9%	129↓44.4%	126↓2.3%	151↑20.2%
Total Assets	251	255↑1.3%	197↓22.5%	220↑11.6%	160↓27.2%
Total Current Liabilities	23	22↓4.3%	31↑41.1%	32↑2.1%	29↓9.3%
Total Liabilities	54	57↑5.8%	40↓29.4%	65↑61.0%	57↓11.4%
Total Equity	197	198↑0.1%	157↓20.5%	156↓1.0%	103↓33.7%
Total Debt	1	1↓1.3%	0↓37.7%	0	2
Net Debt	-27	-45↓67.3%	-39↑11.5%	-25↑37.7%	-18↑27.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-52	-68↓29.6%	-78↓15.9%	-20↑74.4%	-47↓134.7%
Capital Expenditure	-0	-1↓96.4%	-1↓116.4%	-0↑90.8%	-0↑8.3%
Free Cash Flow	-52	-68↓30.0%	-80↓16.8%	-20↑74.6%	-47↓133.3%
Stock-Based Comp	14	15↑7.0%	21↑36.6%	11↓47.2%	12↑14.1%
Net Change in Cash	5	18↑239.2%	-5↓130.1%	-15↓183.5%	-5↑69.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance